7th Oct 2015 07:00
Press Release | 07 October 2015 |
Quantum Pharma Plc
("Quantum" or the "Group")
Notice of Half Year Results
Quantum Pharma Plc (AIM: QP.), the growing service-led niche pharmaceutical manufacturer, developer and supplier to the health and care sectors, today confirms that the Group will announce its Half Year Results for the half year ended 31 July 2015 on Tuesday, 20 October 2015. An analyst briefing given by Andrew Scaife (Chief Executive Officer) and Martin Such (Chief Financial Officer), will be held at 9.30 a.m. on Tuesday, 20 October 2015 at the offices of Abchurch Communications, 125 Old Broad Street, London, EC2N 1AR.
- Ends -
For further information:
Quantum Pharma Plc |
| |
Andrew Scaife, Chief Executive Officer | Tel: +44 (0) 1207 279 404 | |
Martin Such, Chief Financial Officer | www.quantumpharmaplc.com
| |
Zeus Capital Limited (Nominated Adviser & Broker) |
| |
Andrew Jones / Nick Cowles / Jamie Peel | Tel: +44 (0) 161 831 1512 | |
Dominic Wilson / John Goold | Tel: +44 (0) 20 7533 7727 | |
| www.zeuscapital.co.uk | |
|
| |
Media enquiries:
Abchurch |
|
Jamie Hooper / Alex Shaw | Tel: +44 (0) 20 7398 7719 |
www.abchurch-group.com |
Related Shares:
Quantum Pharma